These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14694854)

  • 1. Diabetic nephropathy. Aspects of pathophysiology and treatment.
    Hansen HP
    Dan Med Bull; 2003 Nov; 50(4):401-22. PubMed ID: 14694854
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic nephropathy.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S69-72. PubMed ID: 12017684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment].
    Braam B; de Koning EJ; Mees EJ
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):212-7. PubMed ID: 14983575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of progression of diabetic nephropathy. Conclusions based on clinical observations.
    Aurell M; Björck S
    Contrib Nephrol; 1992; 98():125-32. PubMed ID: 1493724
    [No Abstract]   [Full Text] [Related]  

  • 5. What does the term "diabetic kidney disease" mean and what is the dietary intervention?
    Marcason W
    J Am Diet Assoc; 2008 Jul; 108(7):1268. PubMed ID: 18589038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetic nephropathy and arterial hypertension].
    Chaignon M; Guédon J
    Journ Annu Diabetol Hotel Dieu; 1993; ():203-14. PubMed ID: 8331866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes mellitus and microalbuminuria].
    Krusová D
    Vnitr Lek; 2007 Dec; 53(12):1310-8. PubMed ID: 18357867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and treatment of diabetic nephropathy.
    Viberti GC
    Contrib Nephrol; 1989; 75():117-26. PubMed ID: 2560691
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic nephropathy: etiology and prevention.
    Viberti GC; Walker JD
    Diabetes Metab Rev; 1988 Mar; 4(2):147-62. PubMed ID: 3281807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress on diagnosis and therapy of diabetic nephropathy].
    Hotta N; Kakuta N
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):31-7. PubMed ID: 1348264
    [No Abstract]   [Full Text] [Related]  

  • 11. The Bermuda Triangle: hypertension, diabetes mellitus and nephropathy.
    Narain VS; Kochar A; Gupta R; Puri VK
    Indian Heart J; 2000; 52(3):346-50. PubMed ID: 10976162
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic nephropathy. Are the blood pressure values set too low?].
    Zidek W
    MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment].
    Luik PT; Visser FW; Dullaart RP; Navis GJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(17):855-6; author reply 856. PubMed ID: 15141656
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current approaches to the prevention and treatment of diabetic nephropathy].
    Shestakova MV; Dedov II
    Ter Arkh; 1994; 66(6):75-8. PubMed ID: 7940378
    [No Abstract]   [Full Text] [Related]  

  • 16. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
    de Boer IH; Steffes MW
    J Am Soc Nephrol; 2007 Apr; 18(4):1036-7. PubMed ID: 17360946
    [No Abstract]   [Full Text] [Related]  

  • 17. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.
    Estacio RO; Schrier RW
    Adv Intern Med; 2001; 46():359-408. PubMed ID: 11147259
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.